Skip to main content

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

KYMR holding history

Kymera Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KYMR overviewAll 13F holders of KYMRFull Q2 2026 holdings

Shares (Q2 2026)
8,657,242
Value
$992.7M
% of portfolio
5.0%
Quarters held
22
Since Q1 2021
Holdings of KYMR by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,657,242$992.7M5.0%00.0%UnchangedHolders
Q1 20268,657,242$721.1M4.1%00.0%UnchangedHolders
Q4 20258,657,242$673.6M3.9%+2,005,813+30.2%AddedHolders
Q3 20256,651,429$376.5M2.7%00.0%UnchangedHolders
Q2 20256,651,429$290.3M2.8%+655,500+10.9%AddedHolders
Q1 20255,995,929$164.1M1.8%00.0%UnchangedHolders
Q4 20245,995,929$241.2M2.6%00.0%UnchangedHolders
Q3 20245,995,929$283.8M2.9%+10.0%AddedHolders
Q2 20245,995,928$179.0M2.3%00.0%UnchangedHolders
Q1 20245,995,928$241.0M3.0%00.0%UnchangedHolders
Q4 20235,995,928$152.7M1.7%+1,245,528+26.2%AddedHolders
Q3 20234,750,400$66.0M0.4%+375,060+8.6%AddedHolders
Q2 20234,375,340$100.6M0.6%+1,495,515+51.9%AddedHolders
Q1 20232,879,825$85.3M0.5%00.0%UnchangedHolders
Q4 20222,879,825$71.9M0.4%00.0%UnchangedHolders
Q3 20222,879,825$62.7M0.4%00.0%UnchangedHolders
Q2 20222,879,825$56.7M0.3%+495,083+20.8%AddedHolders
Q1 20222,384,742$100.9M0.6%00.0%UnchangedHolders
Q4 20212,384,742$151.4M0.7%00.0%UnchangedHolders
Q3 20212,384,742$140.1M0.6%+425,531+21.7%AddedHolders
Q2 20211,959,211$95.0M0.4%00.0%UnchangedHolders
Q1 20211,959,211$76.1M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.